All In Biotech

Drug Trial Radar · NCT03548220

A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Subjects With Pyruvate Kinase Deficiency

Last checked: Nov 19, 2026Latest source record: May 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

80

Actual

Start

Aug 9, 2018

Primary completion

Oct 9, 2020

Study completion Oct 9, 2020

Sponsor

Lead sponsor
Agios Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jun 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study AG348-C-006 evaluated the efficacy and safety of orally administered AG-348 as compared with placebo in participants with pyruvate kinase (PK) deficiency, who were not regularly receiving blood transfusions. Participants were randomized 1:1 to receive either AG-348 or a matching placebo.

Conditions

  • Pyruvate Kinase Deficiency
  • Anemia, Hemolytic

Interventions

  • PlaceboDrug

    Placebo matching AG-348 tablets, administered to maintain the blind.

  • AG-348Drug

    AG-348 tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving a Hemoglobin (Hb) Response (HR)Time frame: Baseline, Weeks 16, 20, 24

Locations

46 sites in 16 countries. Site status is shown where the registry gives one.

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Emory University

    Atlanta, Georgia

  • Indiana Hemophilia and Thrombosis Center

    Indianapolis, Indiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • The Children's Hospital Corporation d/b/a Boston's Children Hospital

    Boston, Massachusetts

  • Wayne State University School of Medicine, Children's Hospital of Michigan

    Detroit, Michigan

  • Duke University

    Durham, North Carolina

  • East Carolina University

    Greenville, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Houston Methodist Research Institute

    Houston, Texas

  • Primary Children's Hospital Univ. of Utah

    Salt Lake City, Utah

  • Seattle Cancer Care Alliance

    Seattle, Washington

  • Hospital Central da Faculdade de Medicina USP Cidade Universitaria

    São Paulo, Brazil

  • McMaster University - Health Sciences Centre

    Hamilton, Canada

  • Toronto General Hospital, University Health Network

    Toronto, Canada

  • Institute of Hematology and Blood Transfusion

    Prague, Czechia

  • University of Copenhagen, Herlev Hospital

    Herlev, Denmark

  • CHU Amiens Picardie

    Amiens, France

  • Hopital Saint-Andre

    Bordeaux, France

  • Hôpital Henri-Mondor

    Créteil, France

  • Hôpital de la Timone

    Marseille, France

  • Institut Claudius Regaud

    Toulouse, France

  • Charite University Medicine

    Berlin, Germany

  • Universitätsklinikum Würzburg

    Würzburg, Germany

  • Ospedale Galliera

    Genova, Italy

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    Milan, Italy

  • AOU Policlinico, Università della Campania "Luigi Vanvitelli"

    Naples, Italy

  • Kyoto Katsura Hospital

    Kyoto, Japan

  • Agios Investigative Site

    Mie, Japan

  • Osaka City General Hospital

    Osaka, Japan

  • Kansai Medical University, Department of Pediatrics, Hirakata Hospital

    Osaka, Japan

  • Toho University Omori Medical Center

    Tokyo, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, Japan

  • Universitair Medisch Centrum Utrecht

    Utrecht, Netherlands

  • Yeungnam University Hospital

    Daegu 705-703, South Korea

  • Hospital U. Vall d'Hebron Servicio de Hematología Clínica

    Barcelona, Spain

  • Hospital Clinico Universitario Virgen de la Arricaxa

    El Palmar, Spain

  • Hospital Universitario La Paz

    Madrid, Spain

  • Centre Hospitalier Universitaire Vaudois (CHUV)

    Lausanne, Switzerland

  • Department of Paediatrics and Thalassaemia Center, Faculty of Medicine Siriraj

    Bangkok, Thailand

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.